Cargando…

The Risk of Tuberculosis in Korean Patients with Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α Blockers

The aims of this study were to assess the risk of tuberculosis (TB) and the status of latent tuberculosis infection (LTBI) in Korean patients with inflammatory bowel disease (IBD) receiving tumor necrosis factor (TNF)-α blockers. We reviewed medical records of 525 Korean IBD patients (365 TNF-α bloc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byun, Ja Min, Lee, Chang Kyun, Rhee, Sang Youl, Kim, Hyo-Jong, Kim, Jung-Wook, Shim, Jae-Jun, Jang, Jae Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310944/ https://www.ncbi.nlm.nih.gov/pubmed/25653489 http://dx.doi.org/10.3346/jkms.2015.30.2.173

Ejemplares similares

Polymorphisms in PRKCDBP, a Transcriptional Target of TNF-α, Are Associated With Inflammatory Bowel Disease in Korean
por: Kim, Jung-Wook, et al.
Publicado: (2015)

Incidences of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-α Therapy
por: Yoo, In Kyung, et al.
Publicado: (2014)

Diabetes Status and Association With Risk of Tuberculosis Among Korean Adults
por: Yoo, Jung Eun, et al.
Publicado: (2021)

Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
por: Lee, Jang Wook, et al.
Publicado: (2016)

A Meta-Analysis of Long- Versus Short-Acting Phosphodiesterase 5 Inhibitors: Comparing Combination Use With α-Blockers and α-Blocker Monotherapy for Lower Urinary Tract Symptoms and Erectile Dysfunction
por: Choi, Hoon, et al.
Publicado: (2015)

Amelioration of cancer cachexia with preemptive administration of tumor necrosis factor-α blocker
por: Kang, Eun A, et al.
Publicado: (2022)

Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea
por: Lee, Jae Yong, et al.
Publicado: (2021)

Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease
por: Kang, Jieun, et al.
Publicado: (2018)

Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
por: Shim, Jae-Jun, et al.
Publicado: (2016)

Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study
por: Gilson, Mélanie, et al.
Publicado: (2010)

Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors
por: Kim, Kyuwon, et al.
Publicado: (2021)

Efficacy of iron supplementation in patients with inflammatory bowel disease treated with anti-tumor necrosis factor-alpha agents
por: Kim, Su Young, et al.
Publicado: (2020)

Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy
por: Sung, Yoon-Kyoung, et al.
Publicado: (2018)

Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy
por: Oh, Kyunghwan, et al.
Publicado: (2023)

Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
por: Hong, Hee Seung, et al.
Publicado: (2022)

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
por: Park, Dong Il, et al.
Publicado: (2018)

Association between Hand Grip Strength and Self-Rated Health in Middle- and Old-Aged Korean Citizens
por: Jang, Sae-Kyun, et al.
Publicado: (2020)

Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography
por: Goo, Ja-Jun, et al.
Publicado: (2014)

Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
por: Kim, Eun Soo, et al.
Publicado: (2016)

Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers
por: Choi, Won Joon, et al.
Publicado: (2022)

Insufficient vaccination and inadequate immunization rates among Korean patients with inflammatory bowel diseases
por: Ryu, Han Hee, et al.
Publicado: (2021)

Depression, Anxiety, Related Risk Factors and Cognitive Distortion in Korean Patients with Inflammatory Bowel Disease
por: Song, Jun Ho, et al.
Publicado: (2020)

Self-reported Food Intolerance in Korean Patients With Irritable Bowel Syndrome
por: Lee, Hyo Jeong, et al.
Publicado: (2019)

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
por: Park, Dong Il, et al.
Publicado: (2018)

The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea
por: Choi, Myeong Geun, et al.
Publicado: (2022)

Pulmonary Impairment in Tuberculosis Survivors: The Korean National Health and Nutrition Examination Survey 2008-2012
por: Jung, Jae-Woo, et al.
Publicado: (2015)

Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy
por: Shim, Tae Sun
Publicado: (2014)

The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-α Antagonist Therapy
por: Jung, Yu Jung, et al.
Publicado: (2015)

Risk of hepatitis B virus-related hepatocellular carcinoma development is much higher in Koreans than in Taiwanese
por: Shim, Jae-Jun, et al.
Publicado: (2017)

Epidemiological and clinical profile of Korean travelers receiving international medical repatriation
por: Kim, Jiena, et al.
Publicado: (2019)

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
por: Kim, Hae Rim, et al.
Publicado: (2013)

AGEs Blocker™ (Goji Berry, Fig, and Korean Mint Mixed Extract) Inhibits Skin Aging Caused by Streptozotocin-Induced Glycation in Hairless Mice
por: Yoo, Jin Hee, et al.
Publicado: (2023)

Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection
por: Son, Chang-Nam, et al.
Publicado: (2014)

Prevalence and risk factors of bowel symptoms in Korean patients with ulcerative colitis in endoscopic remission: a retrospective study
por: Nam, Kwangwoo, et al.
Publicado: (2021)

Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study
por: Choi, Youn I, et al.
Publicado: (2020)

Activation, Impaired Tumor Necrosis Factor-α Production, and Deficiency of Circulating Mucosal-Associated Invariant T Cells in Patients with Scrub Typhus
por: Kang, Seung-Ji, et al.
Publicado: (2016)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

Significant association of SREBP-2 genetic polymorphisms with avascular necrosis in the Korean population
por: Kim, Tae-Ho, et al.
Publicado: (2008)

Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
por: Kang, Eun Ae, et al.
Publicado: (2022)

The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection
por: Atteno, Mariangela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nonhp52qs8daunignaaol91dlv